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H I G H L I G H T S
• Perceptions of harm of tobacco products are important in predicting product use.
• Harm perceptions predict product uptake in non-users and continued use among users.
• Tobacco control strategies may benefit from understanding/addressing perceptions.
A R T I C L E I N F O
Disclaimer: The findings and conclusions in this
report are those of the authors and do not
necessarily represent the official position of the
U.S. Department of Health and Human Services





A B S T R A C T
Objectives: To examine: (1) How perceptions of harm for seven non-cigarette tobacco products predict sub-
sequent use; (2) How change in use is associated with changes in perceptions of product harm; (3) Whether
sociodemographic variables moderate the association between perceptions and use.
Methods: Data are from the adult sample (18+) of the Population Assessment of Tobacco and Health (PATH)
Study, a nationally representative longitudinal cohort survey conducted September 2013-December 2014 (Wave
1 (W1) n=32,320) and October 2014-October 2015 (Wave 2 (W2) n=28,362).
Results: Wave 1 users and non-users of e-cigarettes, filtered cigars, cigarillos, and pipes, who perceived these
products as less harmful had greater odds of using the product at W2. For the other products, there was an
interaction between W1 perceived harm and W1 use status in predicting W2 product use. At W2, a smaller
percentage of U.S. adults rated e-cigarettes as less harmful than cigarettes compared to W1 (41.2% W1, 29.0%
W2). Believing non-cigarette products to be less harmful than cigarettes was more strongly associated with
subsequent product use in the oldest age group (55+ years) while weaker effects were observed in the youngest
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age group (18–24 years). This moderating effect of age was significant for e-cigarettes, hookah, traditional ci-
gars, and cigarillos.
Conclusions: Strategies to prevent initiation and promote cessation of these products may benefit from under-
standing and addressing perceptions of these products.
1. Introduction
Different tobacco products can present qualitatively and quantita-
tively different risks to the user, even within a product class (classes
include, but are not limited to: cigarettes, e-cigarettes, cigars, cigarillos,
hookah, pipes or smokeless tobacco). However, scientific and public
health organizations are frequently making broad distinctions between
product classes in terms of their overall health risks (Drope et al., 2017;
Royal College of Physicians, 2016; U.S. Department of Health and
Human Services, 2016). For example, the 2018 Report of the U.S. Na-
tional Academies of Sciences, Engineering, and Medicine (NASEM)
concludes that “there is conclusive evidence that completely sub-
stituting e-cigarettes for combusted cigarettes reduces one’s exposure to
toxicants and carcinogens and substantial evidence that complete
switching reduces short-term adverse health outcomes” (National
Academies of Sciences, 2018). Given that the burning of combusted
products generates a wider range and higher levels of toxicants com-
pared to non-combusted products, combustible products are recognized
as generally more harmful than non-combustible ones to long-term
users of each product type (Kiviniemi & Kozlowski, 2015), although this
may not apply to all specific products and disease endpoints.
Tobacco product consumers’ beliefs about product risk often do not
align with scientific bodies’ conclusion that combustible products
generally tend to be more harmful than non-combustible ones to long-
term users of each product type (Fong et al., 2019; Kiviniemi &
Kozlowski, 2015; O'Connor et al., 2007). In one recent nationally re-
presentative sample of United States (U.S.) adults, fewer than half
(40.7%) believed that e-cigarettes were less harmful than cigarettes,
and hookah was the next most likely product to be perceived as less
harmful than cigarettes (17.8% of respondents). In contrast, smokeless
tobacco was most likely to be perceived as more harmful than cigarettes
(27.6%) (Fong et al., 2019).
Perceptions of product harm have been associated with product use,
as users of tobacco products report lower perceptions of product harm
than non-users (Fong et al., 2019). The same study also demonstrated
an association between lowered perceptions of harm of eight tobacco
products (e-cigarettes, hookah, traditional cigars, filtered cigars, snus,
smokeless tobacco, pipes, and cigarillos), and increased likelihood of
using the product (Fong et al., 2019). A limitation of much of the ex-
isting nationally representative research conducted in the U.S. is that it
relies on cross-sectional data. Of the few longitudinal studies that have
been conducted to date, a U.S. longitudinal cohort survey of young
adults (aged 18–24) also demonstrated that perceptions of the relative
harm of hookah were associated with hookah initiation 6months later
(Villanti, Cobb, Cohn, Williams, & Rath, 2015). Two U.S. nationally
representative longitudinal cohort studies of adolescents have found
that perceptions of lower harm of tobacco products relative to cigar-
ettes at baseline are associated with greater likelihood of product use at
follow-up (Parker et al., 2018; Strong et al., 2019). Additionally, a study
of U.S. adult dual users of cigarettes and e-cigarettes found that per-
ceiving e-cigarettes as less harmful than cigarettes predicted completely
switching to e-cigarettes one year later (Persoskie, O'Brien, & Poonai,
2019). No studies to date have examined how perceptions of the re-
lative harm of a variety of tobacco products relate to subsequent pro-
duct use in a nationally representative U.S. longitudinal cohort sample
of adults. Previous research has also demonstrated significant varia-
bility in perceptions of the harm of non-cigarette tobacco products by
socio-demographic groups (Fong et al., 2019), raising the possibility
that harm perceptions among sub-populations may in part explain
differences in patterns of use.
Because perceptions of product harm are shown to be associated
with subsequent product use, it is important to monitor harm percep-
tions of product consumers as these often help to explain changing
patterns of tobacco use. Recent changes in the prevalence of e-cigarette
and hookah use (Arrazola et al., 2015; Centers for Disease Control and
Prevention, 2013; Dockrell, Morrison, Bauld, & McNeill, 2013; King,
Alam, Promoff, Arrazola, & Dube, 2013) may be driven in part by
changing beliefs about product harm (Majeed et al., 2017; Tan &
Bigman, 2014). Tracking product harm perceptions is therefore im-
portant to the Food and Drug Administration’s (FDA) efforts to regulate
tobacco products and their marketing.
Using nationally representative, longitudinal data from the
Population Assessment of Tobacco and Health (PATH) Study, this paper
addresses gaps in the existing literature to achieve the following spe-
cific aims across all US adults: (1) to examine how Wave 1 perceptions
of harm for 7 non-cigarette tobacco products (e-cigarettes, traditional
cigars, cigarillos, filtered cigars, hookah, pipes, and smokeless tobacco),
relative to cigarettes, predict product use at Wave 2 (in terms of in-
itiation, cessation, continued use/non-use); (2) to examine how tobacco
product use (initiation, cessation, continued use/non-use) between
Waves 1 and 2 is associated with changes in perceptions of tobacco
product harm; and (3) to examine whether sociodemographic variables
(e.g., gender, age, sexual orientation, socioeconomic status, race/eth-
nicity) moderate the association between harm perceptions and sub-
sequent product use.
2. Methods
The PATH Study is an ongoing, nationally representative, long-
itudinal cohort study of adults and youth in the U.S. The PATH Study
uses audio computer-assisted self-interviews (ACASI), available in
English and Spanish, to collect self-reported information on tobacco-use
patterns and associated health behaviors. Wave 1 data collection was
conducted from September 12, 2013 to December 14, 2014; Wave 2
was conducted from October 23, 2014 to October 30, 2015. Wave 2
interviews were conducted as close as possible to the 1-year anniversary
of each respondent’s wave 1 interview. The PATH Study recruitment
employed a stratified address-based, area-probability sampling design
at Wave 1 that oversampled adult tobacco users, young adults (18 to
24 years), and African-American adults. An in-person screener was used
at Wave 1 to select youths and adults from households for participation.
Population and replicate weights were created that adjusted for the
complex study design characteristics (e.g., oversampling at Wave 1),
and for nonresponse at Waves 1 and 2. Combined with the use of a
probability sample, the weights allow analyses of the PATH Study data
to compute estimates that are representative of the non-in-
stitutionalized, civilian U.S. population ages 12 years and older. The
analyses were conducted using the Restricted Use Data File (RUF).
Further details regarding the PATH Study design and methods are
published elsewhere (Hyland et al., 2017). Details on survey interview
procedures, questionnaires, sampling, weighting, and information on
accessing the data are available at http://doi.org/10.3886/Series606.
The study was conducted by Westat and approved by the Westat in-
stitutional review board. All participants (18 and older) provided in-
formed consent.
At Wave 1, the weighted response rate for the household screener
was 54.0%. Among households that were screened, the overall
weighted response rate at Wave 1 was 74.0% for the Adult Interview. At
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Wave 2, the overall weighted response rate was 83.2% for the Adult
Interview.
At Wave 1, interviews were completed with 32,320 adults (ages
18 years and older). Data for this analysis were based on 26,446 adults
(age 18 or older at Wave 1) who responded to the Adult Interview at
Wave 1 and Wave 2. The differences in number of completed interviews
between Wave 1 and Wave 2 reflect attrition due to non-response,
mortality, and other factors. Adolescents at Wave 1 who were adults at
Wave 2 (n=1,915) were not included in the analyses because ques-
tions about the perceived harm of each tobacco product differed in the
Youth Interview.
2.1. Measures
2.1.1. Awareness of tobacco products
At Wave 1, respondents were presented a brief description and
shown pictures of tobacco products (except cigarettes) and asked
whether they had seen or heard of each of the following: e-cigarettes,
traditional cigars, cigarillos and filtered cigars, hookah, pipes, and
smokeless tobacco (such as snus pouches, loose snus, moist snuff, dip,
spit or chewing tobacco). Only respondents who had heard of each non-
cigarette product were asked subsequent questions about perceptions of
harm and use of that product. At Wave 2, it was assumed that all re-
spondents had heard of all products given that they had been asked
questions about them at Wave 1.
2.1.2. Perceptions of harm
For each product, respondents were asked if smoking/using the
product is “less harmful, about the same, or more harmful than smoking
cigarettes?” Follow-up responses of “don’t know” were only available
when respondents skipped the initial question. Questions for e-cigar-
ettes and smokeless tobacco (including snus pouches) replaced
“smoking” with “using.” Consistent with previous research (Fong et al.,
2019), for each of the two perceived harm variables, we created binary
variables for less harmful (1= less harmful and 0=more/the same/
don't know) and more harmful (1=more harmful and 0= less/the
same/don't know). To examine changes in perceptions of tobacco pro-
duct harm over time, we compared Wave 1 and Wave 2 perceptions of
the harm of each product. Perceptions were coded as “decreased per-
ception of harm” if respondents indicated that the product was “more
harmful” at Wave 1 and “about the same or “less harmful” at Wave 2 or
if respondents indicated that the product was “about the same” at Wave
1 and “less harmful” at Wave 2. Perceptions were coded as “increased
perception of harm” if respondents indicated that the product was “less
harmful” at Wave 1 and “about the same” or “more harmful” at Wave 2
or if the respondents indicated that the product was “about the same” at
Wave 1 and “more harmful” at Wave 2. Perceptions were coded as “no
change” if respondents indicated the same response at both Wave 1 and
Wave 2.
2.1.3. Non-cigarette tobacco product use
Consistent with previous research, current users of non-cigarette
tobacco products were identified as those who currently used the spe-
cific tobacco product “every day” or “some days” (National Academies
of Sciences, 2018). Respondents who were not current product users
(including never and formers users) were classified as non-users.
Changes in product use categories were constructed according to the
following four groups: non-users at Wave 1 who remained non-users at
Wave 2, non-users at Wave 1 who became current users at Wave 2,
current users at Wave 1 who became non-users at Wave 2, and current
users at Wave 1 who remained current users at Wave 2.
2.1.4. Covariates
Demographic measures were from Wave 1 assessment and included
gender, age (derived using the imputed variable in the Restricted Use
File (RUF)1), race/ethnicity (derived using the imputed variable in the
RUF), sexual orientation, educational attainment, and household in-
come. Cigarette smoking status at Wave 1 was also a covariate. Re-
spondents who smoked≥ 100 cigarettes in their lifetime and currently
smoke every day or some days were coded as “current established ci-
garette smokers”; respondents who were never smokers, who had
smoked < 100 cigarettes, or who currently did not smoke at all were
coded as non-current cigarette smokers.
2.2. Statistical analysis
Analyses were conducted using SUDAAN 11.0.1. Statistical methods
appropriate for complex survey data were used to estimate for each
non-cigarette tobacco product the percentage of U.S. adults believing
that product to be less harmful than cigarettes. Variances were esti-
mated using Balanced Repeated Replication (BRR) with a Fay adjust-
ment factor of 0.3 (Judkins, 1990; McCarthy, 1969). Estimates were
weighted to be representative of the U.S. adult population. Logit con-
fidence limits (95% confidence intervals) were estimated for descriptive
statistics. An omnibus test for each covariate was used to determine the
significance of each factor in logistic regression models and relation-
ships described using odds ratios.
To examine how baseline perceptions of harm were associated with
subsequent Wave 2 use among Wave 1 users and non-users, we esti-
mated separate logistic regression models (one for each product) using
Wave 1 perceptions of harm as the primary explanatory variable, along
with Wave 1 use of that product. The interaction between Wave 1
perceptions and product use was also tested, using Wald F tests, to
determine whether product use modified the relationship between
Wave 1 perceptions of harm and product use at Wave 2. All models
controlled for demographic covariates and cigarette smoking status
(current established cigarette smoker vs. non-current cigarette smoker),
measured at Wave 1.
Overall frequencies of the perception that each product was less
harmful than cigarettes were calculated and included the response
“don’t know” and at Wave 1 “hadn’t heard of the product”. However,
respondents who indicated “don’t know” at either wave or “hadn’t
heard of the product” at Wave 1 were excluded from the statistical
models looking at changes in perceptions of harm given that we were
unable to quantify the direction of change (the percentages of “don’t
know” by product are provided in Fig. 1). Multinomial logistic regres-
sion was used to estimate how perceptions of harm changed over time
(decreased, increased or stayed the same). These models estimated
whether changes in product use, entered as the interaction between
Wave 1 and Wave 2 use, were associated with a change in harm per-
ceptions. One model was estimated for each product and marginal es-
timates of the proportion of the population changing their perceptions
were estimated controlling for demographic covariates and cigarette
smoking status. Thus, these models were used to estimate, for example,
how perceptions changed among non-users of a given product who
remained non-users of that product, vs. how perceptions changed
among non-users who started using that product. Similarly, changes in
perceptions were estimated for users who remained users and users who
stopped using a particular product. Changes in perceptions (marginal
differences in prevalence rates) were tested using a t-test for re-
spondents who had change in use (or no use) of a product, compared
with respondents who had no change in use (or no use) of that product
from Wave 1 to Wave 2; p-values were adjusted for multiple compar-
isons using a Bonferroni correction.
Finally, we conducted logistic regression analysis to test whether
sociodemographic factors (i.e., gender, age, race/ethnicity, sexual
1 Missing data on age, gender, race, Hispanic ethnicity, and adult education
were imputed as described in the PATH Study Restricted Use File User’s Guide
(United States Department of Health and Human Services 2015. http://www.
icpsr.umich.edu/icpsrweb/NAHDAP/series/00606)
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Fig. 1. Perceptions of the harm of using non-cigarette tobacco products among adults at Waves 1 and 2 of the PATH Study (Weighted).
Fig. 2. Wave 1 perceptions of product harm (compared to cigarettes) predicting Wave 2 use of non-cigarette tobacco products in the PATH Study.
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orientation, education, and income) modified the relationship between
harm perceptions of each product at Wave 1 and subsequent use of that
product in Wave 2. Separate models were estimated to test the inter-
action of each demographic covariate with baseline perceptions of
harm for each product, and each of these models controlled for all other
demographic covariates, baseline cigarette smoking status and baseline
use of each product. F-tests were used to test the significance of the
overall interaction. Denominator degrees of freedom for all tests was
100. For filtered cigars, the “Asian” category was collapsed with the
“other” category. For cigarillos, “something else” was collapsed with
the “lesbian/gay/bisexual” category due to low sample sizes to allow
the model to be reliably estimated.
3. Results
Overall frequencies of the perceptions of the relative harm of non-
cigarette tobacco products at Wave 1 and Wave 2 are presented in
Fig. 1. The greatest overall change in perceptions was for e-cigarettes:
the perception that e-cigarettes are less harmful than cigarettes de-
clined from 41.2% to 29.0%. There were few other changes in per-
ceptions, at the aggregate level: there was a decline in the perception
that hookah is less harmful than cigarettes (17.8% to 13.6%) and a
decline that traditional cigars are less harmful than cigarettes (12.3% to
8.6%). There was also an increase at each wave in the perception that
the harm of each product is “the same” as cigarettes (Fig. 1).
3.1. Perceptions of relative harm of products and subsequent product use
Fig. 2 summarizes results showing the relationship between Wave 1
perceptions of product harm compared to cigarettes and subsequent use
of that product assessed at Wave 2.
For example, 6.6% of respondents were e-cigarette users at Wave 1
and 93.4% were non-users. At Wave 2, 6.5% were e-cigarette users.
Among non-users at Wave 1, 3.5% became users by Wave 2 whereas
48.9% of e-cigarette users at Wave 1 remained users at Wave 2.
Perceptions that a product was less harmful at Wave 1 was associated
with an increased likelihood of using the product at Wave 2, although
differences were not always statistically significant. Among both Wave
1 users and non-users of e-cigarettes (OR=1.97, 95% CI 1.74–2.22),
filtered cigars (OR=1.61, 95% CI 1.15–2.25), cigarillos (OR=1.86,
95% CI 1.51–2.30), or pipes (OR=2.11, 95% CI 1.44–3.09), re-
spondents who perceived these products as less harmful at Wave 1 had
greater odds of using the product at Wave 2. There was no significant
interaction between Wave 1 use and perceptions of harm predicting
Wave 2 use for these four tobacco products.
There was a significant interaction between product use at Wave 1
and the perceptions of harm predicting subsequent use at Wave 2 for
three tobacco products (smokeless, hookah, and traditional cigars). For
example, among hookah non-users at Wave 1, respondents who per-
ceived that hookah was less harmful than cigarettes were significantly
more likely to use hookah (OR=2.64, 95% CI 2.12–3.28) at Wave 2,
compared with those perceiving the product as more harmful, about the
same, or didn’t know. This association between Wave 1 harm
Table 1
Changes in perceptions of the harmfulness of non-cigarette tobacco products by wave 1-wave 2 product use.
Change in Perceptions
Decreased Increased No Change
NCTP Product NCTP Transtion Wave 1→Wave 2 %*(SE) %*(SE) %*(SE)
E-cigarettes (n= 20,628) Non-user→Non-user 11.3 (0.31) (a) 24.8 (0.48) (b) 64.0 (0.46)
Non-user→User 21.9 (1.42) (a) 13.5 (1.14) (b) 64.6 (1.84)
User→Non-user 7.0 (0.73) 33.3 (1.48) (c) 59.7 (1.59) (d)
User→User 6.5 (0.70) 15.2 (1.09) (c) 78.3 (1.25) (d)
Smokeless (n= 19,484) Non-user→Non-user 18.4 (0.41) 15.1 (0.39) 66.6 (0.52)
Non-user→User 23.2 (3.86) 12.8 (3.40) 64.0 (4.51)
User→Non-user 12.5 (1.83) 24.1 (2.47) 63.3 (2.97)
User→User 12.1 (1.17) 17.2 (1.32) 70.6 (1.34)
Hookah (n= 18,393) Non-user→Non-user 16.6 (0.41) 15.2 (0.36) 68.2 (0.53) (e)
Non-user→User 22.3 (2.21) 17.8 (2.05) 59.9 (2.73) (e)
User→Non-user 9.8 (0.98) (f) 22.2 (1.45) 68.0 (1.68)
User→User 14.2 (1.27) (f) 19.0 (1.59) 66.8 (1.77)
Cigars (n= 13,565) Non-user→Non-user 14.8 (0.46) 15.4 (0.49) 69.8 (0.64)
Non-user→User 20.2 (3.74) 13.7 (2.82) 66.1 (4.28)
User→Non-user 13.8 (1.26) 16.0 (1.32) 70.2 (1.65)
User→User 13.7 (1.19) 14.6 (1.44) 71.7 (1.77)
Filtered cigars (n= 18,566) Non-user→Non-user 13.3 (0.37) 11.8 (0.36) 74.9 (0.47)
Non-user→User 14.9 (2.35) 10.6 (1.57) 74.5(2.34)
User→Non-user 10.5 (1.46) 17.5 (1.86) 71.9 (1.84)
User→User 12.5 (1.80) 12.2 (1.97) 75.3 (2.58)
Cigarillos (n= 18,194) Non-user→Non-user 14.0 (0.37) 12.3 (0.36) 73.7 (0.42)
Non-user→User 18.2 (2.31) 9.8 (1.25) 72.0 (2.31)
User→Non-user 12.1 (1.00) 18.3 (1.26) 69.6 (1.44)
User→User 11.5 (1.36) 16.9 (1.66) 71.6 (2.11)
Pipe (n= 20,941) Non-user→Non-user 14.7 (0.36) 14.7 (0.35) 70.6 (0.44)
Non-user→User 16.5 (3.50) 12.1 (3.85) 71.4 (4.60)
User→Non-user 10.2 (1.75) 21.3 (2.69) 68.6 (2.99)
User→User 18.0 (2.90) 16.9 (2.95) 65.1 (3.30)
*Adjusted for: Gender, age group, race/ethnicity, sexual orientation, education, income and smoking status.
Significant differences between groups are noted by:
(a) higher percentage of decreased risk perceptions among e-cigarette non-users at Wave 1 who become users vs. stay non-users at Wave 2 (p < 0.001),
(b) higher percentage of increased risk perceptions among e-cigarette non-users at Wave 1 who stayed non-users vs. became users at Wave 2 (p < 0.001),
(c) higher percentage of increased risk perceptions among e-cigarette users at Wave 1 who become non-users vs. stay users at Wave 2 (p < 0.001),
(d) higher percentage of no change in risk perceptions among e-cigarette users at Wave 1 who stayed users at Wave 2 vs. became non-users at Wave 2 (p < 0.001),
(e) higher percentage of no change in risk perceptions among hookah non-users at Wave 1 who stayed non-users at Wave 2 vs. became users at Wave 2 (p=0.03),
(f) higher precentage of increases in risk perceptions among hookah users at Wave 1 who stayed users at Wave 2 vs. became non-users at Wave 2 (p=0.03).
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perception predicting Wave 2 use was non-significant (OR=1.30, 95%
CI 0.99–1.72) among Wave 1 hookah users (Fig. 2). The association
between harm perceptions and Wave 2 product use was stronger among
non-users at Wave 1 for both smokeless tobacco (F-test= 4.67,
p=0.03) and hookah (F-test= 15.57, p < 0.001). In contrast, the
association between harm perceptions and Wave 2 product use was
stronger among Wave 1 traditional cigar users (F-test= 5.89,
p=0.02).
3.2. Changes in perceptions of product harm by use Wave 1-Wave 2
Table 1 summarizes results examining changes in perceptions of
product harm between Wave 1 and Wave 2 by respondent product use.
Across all products and all user categories, the majority of respondents
did not change their perceptions of the harm of each of the tobacco
products over time. There was a significant interaction between Wave 1
and Wave 2 product use category associated with changes in percep-
tions of the relative harm of e-cigarettes and hookah, but no other in-
teraction effects were significant.
A significantly higher percentage of respondents who started using
e-cigarettes between Wave 1 and Wave 2 had decreased perceptions of
harm compared to those who remained non-users of e-cigarettes be-
tween surveys (21.9% vs. 11.3%, respectively). In contrast, a sig-
nificantly greater percentage of non-users of e-cigarettes at Wave 1 who
remained non-users at Wave 2 had increased perceptions of harm,
compared to non-users at Wave 1 who started using e-cigarettes at
Wave 2 (24.8% vs. 13.5%, respectively). In addition, 33.3% of users at
Wave 1 who were not currently using e-cigarettes at Wave 2 had in-
creased perceptions of harm compared to only 15.2% of users who were
currently using e-cigarettes at both waves. A significantly higher per-
centage of users who remained users at Wave 2 (78.3%) had no change
in perceptions of the harm of e-cigarettes compared to users at Wave 1
who became non-users at Wave 2 (59.7%).
Perceptions of the harm of hookah decreased among a significantly
higher percentage of hookah users who remained hookah users (14.2%)
compared to hookah users who stopped using hookah (9.8%). A sig-
nificantly higher proportion of non-users who remained non-users
(68.2%) had no change in perceptions of the harm of hookah relative to
non-users who became users (59.9%).
3.3. Interaction between sociodemographic groups and perceptions of harm
on subsequent use
Supplemental Table 2 presents results from logistic regression
models examining whether sociodemographic factors modified the re-
lationship between perceptions of harm and subsequent use of each of
the non-cigarette tobacco products. In general, sociodemographic fac-
tors did not consistently modify the relationship between harm per-
ceptions and subsequent product use. The exception was age; generally,
believing non-cigarette products to be less harmful than cigarettes was
more strongly associated with subsequent product use in the oldest age
group (55+ years) while weaker effects were observed in the youngest
age group (18–24 years). This moderating effect of age was significant
for e-cigarettes, hookah, traditional cigars, and cigarillos.
4. Discussion
This was the first nationally representative longitudinal cohort
study to date to examine the association between perceptions of the
relative harm of seven tobacco products compared to cigarettes and
subsequent use among U.S. adults. The study demonstrates that harm
perceptions not only predict future product uptake in non-product
users, but also predict continued product use among existing users. This
study also confirms that tobacco product users often have beliefs about
the relative health risks of different tobacco products (Kiviniemi &
Kozlowski, 2015; O'Connor et al., 2007) that are inconsistent with the
conclusions of authoritative sources that combustible tobacco products
are generally more harmful than non-combustible ones to long-term
users of each product type (Drope et al., 2017; FDA, 2018; Royal
College of Physicians, 2016; U.S. Department of Health and Human
Services, 2016). For example, a greater percentage of respondents be-
lieved that smokeless tobacco products were more harmful than cigar-
ettes (Wave 1: 27.8%; Wave 2: 23.9%) than believed that cigarettes
were more harmful (Wave 1: 8.5%; Wave 2: 7.2%). As another example,
at Wave 2, 10.9% of Americans believed that e-cigarettes were more
harmful than cigarettes. Many users of non-cigarette tobacco products
such as a smokeless tobacco also smoke cigarettes, and this may be
attributable to their perception that cigarettes are no worse than other
products (Kozlowski & Sweanor, 2018).
Consistent with recent evidence (Tan & Bigman, 2014), we found a
substantial decrease in the proportion of the population perceiving that
e-cigarettes are less harmful than cigarettes between Waves 1 and 2
(from 41.2% to 29.0%). These findings underscore the importance of
better understanding the factors that help to shape tobacco product
consumer perceptions of relative product harm such as product mar-
keting, government-mandated warnings about product risks (i.e., con-
tent of product warnings), media coverage of product risks, and public
health campaigns (Wackowski, Lewis, & Delnevo, 2016; Wackowski,
Lewis, Delnevo, & Ling, 2013; Wackowski, Lewis, Delnevo, & Ling,
2014). We also found that in each year the percentage of respondents
indicating that they believed that each product was just as harmful as
cigarettes increased, suggesting that there are increasing perceptions
that all products are harmful.
Across all products (except for pipes), the prevalence of having
decreased product harm perceptions was highest in those moving from
non-use to use, and the prevalence of increased harm perceptions was
highest among those who stopped using a product. This finding is
consistent with a cognitive dissonance process in which users of tobacco
products may reduce cognitive dissonance by changing their beliefs to
rationalize their behavior (Fotuhi et al., 2013). In this case, non-ci-
garette tobacco users were more likely to reduce cognitive dissonance
by lowering their perceptions of the harm of the tobacco product,
whereas those who stop using a product would change their perceptions
of harm to be more in line with the perceptions held by non-users,
because they no longer need to rationalize their behaviour. Given that
harm perceptions are important predictors of product use, if users tend
to lower their harm perceptions this would increase their likelihood of
continuing to use.
4.1. Limitations
The study uses self-reporting of perceptions of tobacco product
harm and use. Therefore, the study is subject to limitations inherent to
any study using self-report data such as reporting bias, although studies
examining bias in self-reporting of tobacco use have not found evidence
of bias (Persoskie & Nelson, 2013; Yeager & Krosnick, 2010). As pre-
viously noted (National Academies of Sciences, 2018), the PATH Study
uses a direct comparative measure of product harm relative to cigar-
ettes which would likely provide a more conservative measure of the
harm perception (fewer respondents reporting these products are less
harmful), relative to cigarettes, than if indirect measures had been used
(Kaufman, Suls, & Klein, 2016; Popova & Ling, 2013; Wackowski, Bover
Manderski, & Delnevo, 2016). Additionally, a study comparing direct
and indirect measures found that direct measures may be more valid
(Persoskie, Nguyen, Kaufman, & Tworek, 2017).
5. Conclusions
This study demonstrates the importance of perceptions of the harm
of non-cigarette tobacco products in predicting tobacco product use.
Strategies to promote tobacco product abstinence, cessation, or product
switching may benefit from understanding and addressing perceptions
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of these products.
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